• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

ARRS webinar: Tumor imaging, management with 68Ga DOTATATE PET/CT, 177Lu DOTATATE therapy

Bioengineer by Bioengineer
July 31, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Leesburg, VA, July 25, 2018 — Examining the normal distribution, pitfalls, mimics, and imaging characteristics of various tumors using 68Ga DOTATATE PET/CT and the principles and practice of 177Lu DOTATATE therapy will be the focus of an August 20 webinar hosted by the American Roentgen Ray Society (ARRS).

68Ga tetraazacyclododecanetetraacetic acid-DPhe1-Tyr3-octreotate (DOTATATE) PET/CT has become the preferred imaging modality for initial diagnosis, selection of patients for peptide receptor radionuclide therapy, and localization of unknown primary tumors. 177Lu DOTATATE therapy is approved for treatment of patients with GEP NETs which are locally advanced or un-resectable and progressing despite somatostatin analogue therapy.

This ARRS webinar will present a foundational review of 68Ga DOTATATE PET/CT and 177Lu DOTATATE therapy for practicing radiologists, nuclear medicine physicians, nuclear medicine technologists, residents, and patients.

  • WHO: Rathan Subramaniam, MD, PhD, MPH, AJR Section Editor for Nuclear Medicine and Molecular Imaging; and Erik Mittra, MD, PhD, CCD.
  • WHEN: Wednesday, August 15 at Noon Eastern Time.
  • REGISTRATION: ARRS members as well as non-members may attend this ARRS webinar free of charge. Registration is required at arrs.org/FreeAJRlive. This AJR Live Webinar offers 1 CME Credit.
  • MEDIA REGISTRATION: For accredited media representatives wishing to view the webinar, contact Mike Mason, ARRS Communications Manager, at mmason@arrs or 703-858-4332.

###

Founded in 1900, ARRS is the first and oldest radiology society in the United States, and is an international forum for progress in radiology. The Society's mission is to improve health through a community committed to advancing knowledge and skills in radiology. ARRS achieves its mission through an annual scientific and educational meeting, publication of the American Journal of Roentgenology (AJR) and InPractice magazine, topical symposia and webinars, and print and online educational materials. ARRS is located in Leesburg, VA.

Media Contact

Mike Mason
[email protected]
703-858-4332
@ARRS_Radiology

http://www.arrs.org

http://arrs.org/FreeAJRlive

Share12Tweet8Share2ShareShareShare2

Related Posts

CDK4/6 Inhibitors in Advanced Breast Cancer

October 9, 2025

Unresectable Stage III NSCLC: Current Insights and Challenges

October 9, 2025

Melflufen-Dexamethasone Expands Options for Relapsed Myeloma

October 9, 2025

Key Insights on Retinoblastoma and CSF Metastasis

October 9, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1155 shares
    Share 461 Tweet 288
  • New Study Reveals the Science Behind Exercise and Weight Loss

    101 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    96 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Advancements in Sodium Storage: Na3Fe2PO4P2O7 Insights

Detecting Drug Residues in Pasteurized Donor Milk

3D Printing Revolutionizes Orthopedic Prostheses and Orthoses

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.